Vera Therapeutics, Inc 10-Q for FY2023 Q2
Vera Therapeutics, Inc. (VERA)
10-Q
2023-08-10
For: 2023-06-30
View Original
Added on
April 04, 2026
About this 10-Q
Vera Therapeutics, Inc filed this 10-Q on August 10, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $20.16M
- compared with a net loss of $14.85M a year earlier
- Diluted EPS
- -$0.46
- compared with -$0.55 a year earlier